English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

1 Consultant Biochemist, Apollo Clinic, Newtown, Kolkata 2 Assistant Professor, Department of Biochemistry, College of Medicine and Sagore Dutta Hospital, Kamarhati, Kolkata. 3 Professor and Head, Department of Biochemistry, Institute of Post-graduate Medical Education and Research, Kolkata 4 Associate Professor, Department of Cardiology, ICVS, R.G. Kar Medical College, Kolkata Corresponding Author Sharmistha Chatterjee Assistant Professor, Department of Biochemistry, College of Medicine and Sagore Dutta Hospital, Kamarhati, Kolkata Ph No. 9830477927, Email: sharmisthacmajumder@yahoo.co.in Abstract Benign hyperplasia of prostate and prostatic carcinoma are two important diseases of aging male with very high incidence rate. Androgens have been implicated in the pathogenesis of both BHP and Ca prostate. Dihydrotestosterone (the 5-α reduced derivative of Testosterone) is the major metabolite of testosterone in prostate. So DHT is thought to play an important role in the development and progression of both the diseases. The present study was aimed at assessing the inter-relationship between the tissue level of 5α-dihydrotestosterone and pathogenesis of benign hyperplasia of prostate and prostatic carcinoma. The tissue level of DHT has been estimated in transition zone and peripheral zone of prostate in BHP and Ca prostate patients the comparative analysis of the above parameters suggests that, 5α-DHT is implicated in the pathogenesis of BHP and Ca prostate in a zone-wise manner. The findings of the present study also reveal that, prostatic tissue level of 5α-DHT may be explored as a possible marker for the diagnosis of benign hyperplasia of prostate and prostatic carcinoma.

journal of medical science and clinical research

A Study to Evaluate the Role of Dihydrotestosterone in the Pathogenesis of Benign Hyperplasia of Prostate and Prostatic Carcinoma in Patients Attending a Tertiary Care Hospital in Eastern India